Angiotensin receptor blockers (ARBs) vs placebo or no treatment
Micro‐ to macroalbuminuria Median · people with diabetes and kidney disease
Angiotensin receptor blockers may leads to lower micro‐ to macroalbuminuria Median compared with placebo or no treatment (low certainty).
1 finding from 1 review
- Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes onlyRR 0.44 [0.23, 0.85]5 studies · 815 participantsLow